1 / 7

Analysis of Precision Medicine Market applications and companies’ active in the industry

Precision Medicine Market size was over USD 39 billion in 2015, and is anticipated to grow at 10.5% CAGR from 2016 to 2023.<br><br>Get more details @ https://goo.gl/y9VxzK

Toshitbhat
Download Presentation

Analysis of Precision Medicine Market applications and companies’ active in the industry

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Precision Medicine Market worth $87.7bn by 2023: Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024

  2. KeyInsights from Precision Medicine Market : • Drug discovery technology contributed over USD 9 billion to the global precision medicine market size in 2015, and is estimated to expand at 8.3% CAGR from 2016 to 2023. NGS and other such technologies will open new opportunities for industry participants. Regulation of NGS based test development will help create regulatory processes for genetic test development and application. • The global companion diagnostics market is predicted to reach USD 17 billion by 2023. It plays a significant role in development of targeted drugs, thus speeding up the move towards more precise and individualized pharmacotherapy. • Oncology application was over 30% of the precision medicine market share in 2015. There have been significant developments taken place across the globe in the area of breast cancer and other related cancers. Predictive biomarkers in lung cancer therapy targets receptors such as c-ros oncogene 1 receptor tyrosine kinase (ROS1), Epidermal Growth Factor Receptor (EGFR), Immune Checkpoints, and Anaplastic Lymphoma Kinase (ALK).

  3. Continued... • U.S. precision medicine market share accounted for over 65% of the North American revenue in 2015, and is anticipated to continue witnessing growth due to increased government initiatives. For instance, The President’s budget in 2016 has allocated USD 130 million to the NIH for development of a national research cohort of a million voluntary U.S. participants, and the data is linked to EHR for easy access to academic scientists and physicians. • China contributed 25% to the Asia Pacific precision medicine market size in 2015, mainly due to considerable government initiatives supporting growth in the region. Pfizer, Novartis, Covance, Medtronics, Qiagen, Quest Diagnostics, Roche Holding, Teva Pharmaceuticals, and Biocrates Life Sciences are some notable industry participants.

  4. Europe precision medicine market size, by application, 2013 - 2023 (USD Million)

  5. Browse Full Market Research Report On Precision Medicine Market @ https://goo.gl/Nr1ZHe Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/671

  6. 360° Analysis • Application Trends • Oncology application accounted for over 30% of precision medicine market share in 2015 and will grow at 10.9% CAGR estimations from 2016 to 2023. Oncology is leading the way in utilizing the molecular profile of an individual's cancer genome to optimize disease management. CNS application was valued at over USD 9 billion in 2015. Neurosciences therapeutics has been using the approach for a long time. For instance, the success of Deep Brain Stimulation (DBS) product provides a classic example for application in brain circuitry. • Regional Trends • U.S. precision medicine market share was 65% of the North American revenue in 2015, mainly on account of favorable regulatory landscape. The President’s budget has allocated USD 215 million to NIH, NCI, and FDA for development of novel solutions. • Competitive Market Share • Key industry players contributing to global precision medicine market share include Pfizer, Roche, Covance, Novartis, Qiagen, Biocrates Life Sciences, Teva Pharmaceutical, Nanostring Technologies, Laboratory Corporation of America Holdings, Tepnel Pharma Services, Intomics, Ferrer InCode, Silicon Biosystems, Eagle Genomics, Medtronic, and Quest Diagnostics. Roche is developing an integrated genomics portfolio for next generation sequencing (NGS).

  7. Stay In Touch Website: www.gminsights.com Social Media:

More Related